Cellular Biomedicine Group, Inc.
|Number of Estimates|
Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in New York, NY.
Market Cap: 256 Million
Primary Exchange: NASDAQ
Shares Outstanding: 19.4 Million
Float: 10.3 Million
Sector: Health Technology
Longest drawdown: 1584 trading days
From: 2015-03-23 To: 2020-06-02
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|